TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC
Clinical trial NCT02065362 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02065362
- Sponsor
- Baylor College of Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2017-03-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.